Plasma lipoproteome in Alzheimer’s disease: a proof-of-concept study

被引：0
|
作者：
Danni Li
Fangying Huang
Yingchun Zhao
Peter W. Villata
Timothy J. Griffin
Lin Zhang
Ling Li
Fang Yu
机构：
[1] University of Minnesota,Department of Laboratory Medicine and Pathology
[2] University of Minnesota,Masonic Cancer Center
[3] University of Minnesota,Department of Biochemistry, Molecular Biology, and Biophysics
[4] University of Minnesota,Department of Biostatistics
[5] University of Minnesota,Department of Experimental and Clinical Pharmacology
[6] University of Minnesota,School of Nursing
来源：
Clinical Proteomics | 2018年 / 15卷
关键词：
Alzheimer’s disease; Plasma lipoproteins; Targeted proteomics; Complement C3; Very low-density lipoprotein (VLDL); Intermediate density lipoprotein (IDL); Low density lipoprotein (LDL); High-density lipoprotein (HDL); Biomarker; Diagnosis; Selected reaction monitoring (SRM);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Plasma lipoproteome in Alzheimer's disease: a proof-of-concept study
    Li, Danni
    Huang, Fangying
    Zhao, Yingchun
    Villata, Peter W.
    Griffin, Timothy J.
    Zhang, Lin
    Li, Ling
    Yu, Fang
    CLINICAL PROTEOMICS, 2018, 15
  • [2] Functional imaging of hippocampal dysfunction among persons with Alzheimer's disease: a proof-of-concept study
    Arciniegas, David B.
    Tregellas, Jason R.
    Rojas, Donald C.
    Hewitt, Burlleen
    Anderson, C. Alan
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 779 - 783
  • [3] Elevated Aβ aggregates in feces from Alzheimer's disease patients: a proof-of-concept study
    Pils, Marlene
    Dybala, Alexandra
    Schaffrath, Anja
    Rehn, Fabian
    Kutzsche, Janine
    Bloemeke, Lara
    Tusche, Markus
    Oezduezenciler, Pelin
    Bujnicki, Tuyen
    Kraemer-Schulien, Victoria
    Gramespacher, Hannes
    Schmieschek, Maximilian H. T.
    Barbe, Michael T.
    Onur, Oezguer A.
    Fink, Gereon R.
    Tamguney, Gultekin
    Bannach, Oliver
    Willbold, Dieter
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [4] Can platelet BACE1 levels be used as a biomarker for Alzheimer's disease? Proof-of-concept study
    Decourt, Boris
    Walker, Aaron
    Gonzales, Amanda
    Malek-Ahmadi, Michael
    Liesback, Carolyn
    Davis, Kathryn J.
    Belden, Christine M.
    Jacobson, Sandra A.
    Sabbagh, Marwan N.
    PLATELETS, 2013, 24 (03) : 235 - 238
  • [5] Using Biomarkers to Predict Memantine Effects in Alzheimer's Disease: A Proposal and Proof-Of-Concept Demonstration
    Swerdlow, Neal R.
    Kotz, Juliana E.
    Joshi, Yash B.
    Talledo, Jo
    Sprock, Joyce
    Molina, Juan L.
    Huisa, Branko
    Huege, Steven F.
    Romero, Jairo Alberto
    Walsh, Michael J.
    Delano-Wood, Lisa
    Light, Gregory A.
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 84 (04) : 1431 - 1438
  • [6] Webcam-Based Eye-Tracking of Attentional Biases in Alzheimer's Disease: A Proof-Of-Concept Study
    Greenaway, Anne-Marie
    Hwang, Faustina
    Nasuto, Slawomir
    Ho, Aileen
    CLINICAL GERONTOLOGIST, 2024, 47 (01) : 98 - 109
  • [7] Combined Effect of tDCS and Motor or Cognitive Activity in Patients with Alzheimer's Disease: A Proof-of-Concept Pilot Study
    Fonte, Cristina
    Rotundo, Giorgia
    Varalta, Valentina
    Filosa, Angelica
    Muti, Ettore
    Barletta, Cosimo
    Evangelista, Elisa
    Venturelli, Massimo
    Picelli, Alessandro
    Smania, Nicola
    BRAIN SCIENCES, 2024, 14 (11)
  • [8] Quantitative Measurements of Motor Function in Alzheimer's Disease, Frontotemporal Dementia, and Dementia with Lewy Bodies: A Proof-of-Concept Study
    Kragh, Frederikke Jeppesen
    Bruun, Marie
    Budtz-Jorgensen, Esben
    Hjermind, Lena Elisabeth
    Schubert, Robin
    Reilmann, Ralf
    Nielsen, Jorgen Erik
    Hasselbalch, Steen Gregers
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2018, 46 (3-4) : 168 - 179
  • [9] Gastrointestinal Motility and Response to Levodopa in Parkinson's Disease: A Proof-of-Concept Study
    Safarpour, Delaram
    Brumbach, Barbara H.
    Arena, Monica
    Quinn, Joseph
    Diamond, Sarah
    Nutt, Jay G.
    Pfeiffer, RonaldF.
    MOVEMENT DISORDERS, 2022, 37 (10) : 2153 - 2158
  • [10] Elephants, Parkinson's Disease, and Proof-of-Concept Clinical Trials
    Cedarbaum, Jesse M.
    MOVEMENT DISORDERS, 2018, 33 (05) : 697 - 700
12345